Posaconazole in lung transplant recipients: use, tolerability, and efficacy

Transplant Infectious Disease : an Official Journal of the Transplantation Society
C L RobinsonD Chambers

Abstract

Fungal infection is a common cause of mortality and morbidity in lung transplant recipients (LuTR). Treatment failure to first-line antifungals because of resistance or intolerance is an increasing problem. Posaconazole (PCZ), a triazole antifungal, is an attractive treatment option. We performed a single-center retrospective study to describe the use, tolerability, efficacy, and drug interaction effect (with tacrolimus) of PCZ oral suspension in LuTR. Seventy-eight patients were treated with PCZ oral suspension for prophylaxis (n = 15), pre-emptive treatment (n = 31), and treatment of possible (n = 7) and probable (n = 25) invasive fungal infection. A range of fungal isolates was encountered. Resolution was observed in 52.4% (probable, possible, and pre-emptive treatment groups). Aggregate all-cause 1-year mortality was 12.8%. PCZ was well tolerated with 11.5% of patients experiencing adverse effects. Despite dose adjustment strategies, 11.7% of patients experienced supratherapeutic tacrolimus levels, which in 5 cases was associated with a rise (mean 21.6 μmol/L) in serum creatinine. PCZ is well tolerated and appears effective in the management of fungal infection after lung transplantation. Patients receiving concurrent tacro...Continue Reading

References

Aug 9, 2002·The New England Journal of Medicine·Raoul HerbrechtUNKNOWN Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillu
Apr 12, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A SoléUNKNOWN Valencia Lung Transplant Group
May 18, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Issam I RaadAndrew J Ullmann
Dec 5, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas J WalshJohn R Perfect
Jun 5, 2007·Pharmacotherapy·Angela Sansone-ParsonsTim G Mant
Aug 19, 2007·Transplantation Proceedings·F PuglieseP Pietropaoli
May 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ben De PauwUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Mar 24, 2009·Current Opinion in Pulmonary Medicine·Amparo Solé, Miguel Salavert
Jul 25, 2009·Emerging Infectious Diseases·Susan J HowardDavid W Denning
Aug 4, 2009·Journal of Clinical Pharmacy and Therapeutics·A MotonZ Wang
Mar 12, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasTom M Chiller
Jul 2, 2010·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Aniket VadnerkarCornelius J Clancy
Oct 7, 2010·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Silke SchelenzPaul R Hunter
Nov 9, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Timothy W FeltonDavid W Denning
Mar 23, 2011·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Shahid HusainUNKNOWN ISHLT Infectious Diseases Council Working Group on Definitions
Jun 15, 2011·Mycoses·Jomy George, Annette C Reboli
Jul 14, 2011·Clinical Epidemiology·Jane KriengkauykiatSanjeet S Dadwal
Oct 15, 2011·Expert Opinion on Drug Metabolism & Toxicology·Paul O Gubbins
Oct 18, 2011·Emerging Infectious Diseases·Benjamin J ParkDimitrios P Kontoyiannis
Mar 7, 2012·Antimicrobial Agents and Chemotherapy·Michael J DoltonAndrew J McLachlan
May 4, 2012·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Fiona O ZwaldSuephy C Chen
Jul 31, 2012·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Ashley FeistGordon Yung
Aug 25, 2012·Critical Reviews in Microbiology·Joerg J VehreschildOliver A Cornely
Apr 15, 2014·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·C T DoligalskiB D Alexander

❮ Previous
Next ❯

Citations

Oct 4, 2016·Expert Review of Anti-infective Therapy·Palash Samanta, Nina Singh
May 14, 2021·Transplantation·Wim De MolRobin Vos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.